Clinical Trial Update: Chidamide Combined With Cyclophosphamide, Prednisone, Thalidomide in Treatment of Fragile Patients With Relapse/Refratory Peripheral T Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating chidamide with cyclophosphamide, prednisone, and thalidomide for relapsed/refractory peripheral T cell lymphoma (PTCL).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Chidamide (chidamide)
• PREDNISONE (Prednisone)
• Thalidomide (thalidomide)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Relapse/Refratory Peripheral T Cell Lymphoma | Phase 2 | Status: UNKNOWN